It should be noted that GIPR antagonism paradoxically produces additive weight loss when paired to GLP-1R agonism in preclinical studies (58–60) and that this mechanism appears relevant in patients with obesity (61). This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.